The Origin of CIR

During the time of the Eagleton bill, the industry planned -another landmark self-regulatory program — the Cosmetic Ingredient Review (CIR).

CIR's origins can be traced to a proposed FDA program for the specification and toxicological examination of cosmetic ingredients. After reviewing it, the CTFA Scientific Advisory Committee drafted its proposal for a CTFA sponsored "Reasonably Expected As Safe" (REAS) ingredient evaluation program. The CTFA Board approved the concept in 1975, and the following year the program was named the Cosmetic Ingredient Review.

CIR was launched with the goal of bringing together worldwide published and unpublished data on the safety of cosmetic ingredients for review by an independent expert panel. Within five years of its founding, CIR reviewed 216 commonly used ingredients.

An elaborate set of procedures to govern CIR was developed to satisfy CTFA members, FDA and Congress. To achieve credibility, it was designed to be an open program.

The seven member Expert Panel consists of distinguished scientists from the disciplines of dermatology, pharmacology, chemistry and toxicology. The members are selected by a steering committee and publicly nominated by government agencies, industry and consumers.

CIR continues to be one of CTFA's success stories, winning praise from regulators as well as consumer groups for its efforts to ensure product safety. The industry recognizes that by participating in CIR and pooling safety information on cosmetic raw materials, it can minimize the enormous expense and inefficiency of duplicate safety testing.